Andrew James Woodhead

This inventor holds 22 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 13 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Astex Therapeutics Limited, Cancer Research Technology Limited, Concateno Plc. Active years: 2008-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew James Woodhead. Retrieved from https://idiyas.com/inventor/andrew-james-woodhead

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 5)

% Patents Active = 27.3

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 8)

Average Co-Inventor Count = 6.3

ph-index = 6

Forward Citations = 148(Granted Patents)

Location History:

Cambridge, GB (2008 - 2018)
Monmouth, GB (2012 - 2020)
Histon, GB (2022)

Company Filing History:

18 out of 126

Astex Therapeutics Limited

patents

1 out of 268

Cancer Research Technology Limited

Otsuka Pharmaceutical Company, Limited

patents

8. 1 out of 320

Taiho Pharmaceutical Company Limited

patents

9. 1 out of 54

The Institute of Cancer Research: Royal Cancer Hospital

patents

where one patent can have more than one assignee

Years Active: 2008-2022

Loading Chart...

Areas of Expertise:

Pharmaceutical Compounds

HSP90 Inhibitors

Cyclin Dependent Kinases

Oral Fluid Collection

Hydroxybenzamide Derivatives

Dihydroxyphenyl Isoindolylmethanones

Imidazopyridine Derivatives

3,4-Disubstituted 1H-Pyrazole Compounds

Protein Kinase Inhibitors

Therapeutic Combinations

Point of Care Testing

Receptor Tyrosine Kinases

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11466016 - Pharmaceutical compounds (2022-10-11),

2. 10620198 - Device platform for point of care testing (2020-04-14),

3. 9914719 - Hydroxybenzamide derivatives and their use as inhibitors of HSP90 (2018-03-13),

4. 9428439 - Hydrobenzamide derivatives as inhibitors of Hsp90 (2016-08-30),

5. 9179895 - Oral fluid collection device (2015-11-10),

6. 9145354 - Pharmaceutical compounds (2015-09-29),

7. 9051278 - 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators (2015-06-09),

8. 8796244 - Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases (2014-08-05),

9. 8779147 - 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators (2014-07-15),

10. 8779132 - Pharmaceutical compounds (2014-07-15),

11. 8653084 - Hydrobenzamide derivatives as inhibitors of Hsp90 (2014-02-18),

12. 8598217 - Imidazole derivatives and their use as modulators of cyclin dependent kinases (2013-12-03),

13. 8530469 - Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90 (2013-09-10),

14. D673258 - Oral fluid collection device (2012-12-25),

15. 8106057 - Dihydroxyphenyl isoindolylmethanones (2012-01-31),

Title: Andrew James Woodhead - Innovative Inventor from Cambridge, GB

Introduction: Andrew James Woodhead is a renowned inventor based in Cambridge, GB, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Andrew James Woodhead holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, Andrew James Woodhead has established himself as a pioneer in the world of inventions, with numerous successful projects that have had a significant impact on society.

Collaborations: Throughout his career, Andrew James Woodhead has collaborated with leading research institutions, universities, and companies to bring his ideas to life, fostering a culture of innovation and excellence in his work.

Conclusion: Andrew James Woodhead's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future with his groundbreaking creations.

Profile summary based on public USPTO records.